News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication May 14, 2019 Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis Read Now
Publication May 14, 2019 Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review Read Now
Publication May 14, 2019 Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review Read Now
Publication May 14, 2019 Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn’s Disease Read Now
Publication May 14, 2019 Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial Read Now
Publication May 14, 2019 Identifying Outcomes in Clinical Trials of Pouchitis for the Development of a Core Outcome Set Read Now
